{
    "id": "correct_subsidiary_00121_3",
    "rank": 28,
    "data": {
        "url": "https://beststartup.us/meet-united-statess-101-top-ceos-in-the-health-care-space/",
        "read_more_link": "",
        "language": "en",
        "title": "Meet United States's 101 Top CEO's in the Health Care Space",
        "top_image": "https://i0.wp.com/beststartup.us/wp-content/uploads/2022/05/Made-in-America.png?fit=2000%2C1000&ssl=1",
        "meta_img": "https://i0.wp.com/beststartup.us/wp-content/uploads/2022/05/Made-in-America.png?fit=2000%2C1000&ssl=1",
        "images": [
            "https://i0.wp.com/beststartup.us/wp-content/uploads/2023/11/BEST-STARTUP.US-LOGO.png?fit=854%2C130&ssl=1",
            "https://i0.wp.com/beststartup.us/wp-content/uploads/2023/11/BEST-STARTUP.US-LOGO.png?fit=854%2C130&ssl=1",
            "https://secure.gravatar.com/avatar/abd2f6a5c013f56b5e33251960f50fe1?s=80&d=mm&r=g",
            "https://i0.wp.com/beststartup.us/wp-content/uploads/2022/05/Made-in-America.png?fit=2000%2C1000&ssl=1",
            "https://res.cloudinary.com/crunchbase-production/image/upload/c_lpad,h_256,w_256,f_auto,q_auto:eco,dpr_1/aakcrb7lwhx6sppctty7",
            "https://i0.wp.com/res.cloudinary.com/crunchbase-production/image/upload/c_thumb,h_256,w_256,f_auto,g_faces,z_0.7,q_auto:eco,dpr_1/v1468835365/eyyhbcafpbspsmndsie3.png?resize=154%2C152&ssl=1",
            "https://i0.wp.com/res.cloudinary.com/crunchbase-production/image/upload/c_thumb,h_256,w_256,f_auto,g_faces,z_0.7,q_auto:eco,dpr_1/v1503920587/q75ljxddha6dovlzzt4d.jpg?resize=154%2C152&ssl=1",
            "https://res.cloudinary.com/crunchbase-production/image/upload/c_thumb,h_256,w_256,f_auto,g_faces,z_0.7,q_auto:eco,dpr_1/yu3j8mfulakouzc9dumf",
            "https://i0.wp.com/res.cloudinary.com/crunchbase-production/image/upload/c_lpad,h_256,w_256,f_auto,q_auto:eco,dpr_1/v1505723140/wkl5vdtjzn4tdy7ypovb.png?resize=154%2C152&ssl=1",
            "https://res.cloudinary.com/crunchbase-production/image/upload/c_thumb,h_256,w_256,f_auto,g_faces,z_0.7,q_auto:eco,dpr_1/mi97hiefuoogbcwbu3mi",
            "https://i0.wp.com/res.cloudinary.com/crunchbase-production/image/upload/c_thumb,h_256,w_256,f_auto,g_faces,z_0.7,q_auto:eco,dpr_1/v1486704164/mqfuxad6jfvhiffvsnxh.png?resize=154%2C152&ssl=1",
            "https://i0.wp.com/res.cloudinary.com/crunchbase-production/image/upload/c_thumb,h_256,w_256,f_auto,g_faces,z_0.7,q_auto:eco,dpr_1/v1397181585/31c8d9d36bd0e752e2a78e0a579ea53f.jpg?resize=154%2C152&ssl=1",
            "https://res.cloudinary.com/crunchbase-production/image/upload/c_thumb,h_256,w_256,f_auto,g_faces,z_0.7,q_auto:eco,dpr_1/ybaobfssh3ct9nsbbiba",
            "https://res.cloudinary.com/crunchbase-production/image/upload/c_thumb,h_256,w_256,f_auto,g_faces,z_0.7,q_auto:eco,dpr_1/v5jr8itjki8rrzvoffkm",
            "https://i0.wp.com/res.cloudinary.com/crunchbase-production/image/upload/c_lpad,h_256,w_256,f_auto,q_auto:eco,dpr_1/v1397180641/d6a5e73dce32d396a267257b5604d9cb.jpg?resize=154%2C152&ssl=1",
            "https://res.cloudinary.com/crunchbase-production/image/upload/c_lpad,h_256,w_256,f_auto,q_auto:eco,dpr_1/ihhy3dmxb1kmbh0adgvy",
            "https://i0.wp.com/res.cloudinary.com/crunchbase-production/image/upload/c_lpad,h_256,w_256,f_auto,q_auto:eco,dpr_1/v1440422086/s5pt03avsd0sjzzxr8ah.jpg?resize=154%2C152&ssl=1",
            "https://res.cloudinary.com/crunchbase-production/image/upload/c_lpad,h_256,w_256,f_auto,q_auto:eco,dpr_1/fuzdcj0hpvq7vozmezkf",
            "https://i0.wp.com/res.cloudinary.com/crunchbase-production/image/upload/c_lpad,h_256,w_256,f_auto,q_auto:eco,dpr_1/v1397188669/0b546c1b83da61d364f9d0fd547dabc7.jpg?resize=154%2C152&ssl=1",
            "https://i0.wp.com/res.cloudinary.com/crunchbase-production/image/upload/c_lpad,h_256,w_256,f_auto,q_auto:eco,dpr_1/v1455538220/odlwbqxu6g1nnrxwuker.png?resize=154%2C152&ssl=1",
            "https://i0.wp.com/res.cloudinary.com/crunchbase-production/image/upload/c_lpad,h_256,w_256,f_auto,q_auto:eco,dpr_1/v1437976221/bn7xcz7txlgbtxlferhc.png?resize=154%2C152&ssl=1",
            "https://res.cloudinary.com/crunchbase-production/image/upload/c_thumb,h_256,w_256,f_auto,g_faces,z_0.7,q_auto:eco,dpr_1/ma2skitywlni2rkelndi",
            "https://res.cloudinary.com/crunchbase-production/image/upload/c_lpad,h_256,w_256,f_auto,q_auto:eco,dpr_1/rzhbpk6rv1cpdm6hxwx4",
            "https://res.cloudinary.com/crunchbase-production/image/upload/c_lpad,h_256,w_256,f_auto,q_auto:eco,dpr_1/epktck7i7m5oc4xpkkqv",
            "https://i0.wp.com/res.cloudinary.com/crunchbase-production/image/upload/c_lpad,h_256,w_256,f_auto,q_auto:eco,dpr_1/v1442583880/hdjjskagphz3oe1h2joy.jpg?resize=154%2C152&ssl=1",
            "https://res.cloudinary.com/crunchbase-production/image/upload/c_lpad,h_256,w_256,f_auto,q_auto:eco,dpr_1/f8btwbkvg42zxv8uacxg",
            "https://res.cloudinary.com/crunchbase-production/image/upload/c_thumb,h_256,w_256,f_auto,g_faces,z_0.7,q_auto:eco,dpr_1/ermfnljzi2mzmnklrsjr",
            "https://res.cloudinary.com/crunchbase-production/image/upload/c_thumb,h_256,w_256,f_auto,g_faces,z_0.7,q_auto:eco,dpr_1/png8ejx1wug3vv4nq04h",
            "https://i0.wp.com/res.cloudinary.com/crunchbase-production/image/upload/c_thumb,h_256,w_256,f_auto,g_faces,z_0.7,q_auto:eco,dpr_1/v1433172695/z7zlyyxnpmyd64mimhep.jpg?resize=154%2C152&ssl=1",
            "https://res.cloudinary.com/crunchbase-production/image/upload/c_thumb,h_256,w_256,f_auto,g_faces,z_0.7,q_auto:eco,dpr_1/eyj5v8yvgo87o1peluin",
            "https://res.cloudinary.com/crunchbase-production/image/upload/c_lpad,h_256,w_256,f_auto,q_auto:eco,dpr_1/hjldpqwoxvslyczrztxi",
            "https://res.cloudinary.com/crunchbase-production/image/upload/c_lpad,h_256,w_256,f_auto,q_auto:eco,dpr_1/bunni5w7vf0u6yae0rvd",
            "https://i0.wp.com/res.cloudinary.com/crunchbase-production/image/upload/c_lpad,h_256,w_256,f_auto,q_auto:eco,dpr_1/v1472036515/q8var4wosudcc8vnbqef.png?resize=154%2C152&ssl=1",
            "https://i0.wp.com/res.cloudinary.com/crunchbase-production/image/upload/c_thumb,h_256,w_256,f_auto,g_faces,z_0.7,q_auto:eco,dpr_1/v1463635380/kag13u1yi8eozsk7btf9.jpg?resize=154%2C152&ssl=1",
            "https://res.cloudinary.com/crunchbase-production/image/upload/c_lpad,h_256,w_256,f_auto,q_auto:eco,dpr_1/bmzyhccv65jaklotzevc",
            "https://res.cloudinary.com/crunchbase-production/image/upload/c_thumb,h_256,w_256,f_auto,g_faces,z_0.7,q_auto:eco,dpr_1/dd2nhgdbezhosyxfq5gl",
            "https://i0.wp.com/res.cloudinary.com/crunchbase-production/image/upload/c_thumb,h_256,w_256,f_auto,g_faces,z_0.7,q_auto:eco,dpr_1/v1462945231/melqddbcuvdhzwbudhdz.png?resize=154%2C152&ssl=1",
            "https://i0.wp.com/res.cloudinary.com/crunchbase-production/image/upload/c_thumb,h_256,w_256,f_auto,g_faces,z_0.7,q_auto:eco,dpr_1/v1397182754/0c2ac951d0de106125455f9437f01f97.jpg?resize=154%2C152&ssl=1",
            "https://res.cloudinary.com/crunchbase-production/image/upload/c_lpad,h_256,w_256,f_auto,q_auto:eco,dpr_1/hhyqklhzl0eecsx26vph",
            "https://res.cloudinary.com/crunchbase-production/image/upload/c_thumb,h_256,w_256,f_auto,g_faces,z_0.7,q_auto:eco,dpr_1/ad1rvwjjqztwxdmm4srp",
            "https://res.cloudinary.com/crunchbase-production/image/upload/c_lpad,h_256,w_256,f_auto,q_auto:eco,dpr_1/vl49n1yggw0sfkrusoub",
            "https://i0.wp.com/res.cloudinary.com/crunchbase-production/image/upload/c_thumb,h_256,w_256,f_auto,g_faces,z_0.7,q_auto:eco,dpr_1/v1437880792/cum2bl8s1lsq99u6a9d8.png?resize=154%2C152&ssl=1",
            "https://res.cloudinary.com/crunchbase-production/image/upload/c_thumb,h_256,w_256,f_auto,g_faces,z_0.7,q_auto:eco,dpr_1/omzfcil12mpj2n0vf0gy",
            "https://i0.wp.com/res.cloudinary.com/crunchbase-production/image/upload/c_lpad,h_256,w_256,f_auto,q_auto:eco,dpr_1/v1445032467/zjslbg4gg5n7exg8dubg.jpg?resize=154%2C152&ssl=1",
            "https://res.cloudinary.com/crunchbase-production/image/upload/c_lpad,h_256,w_256,f_auto,q_auto:eco,dpr_1/nhtjcohcpdh0skdlyffd",
            "https://i0.wp.com/res.cloudinary.com/crunchbase-production/image/upload/c_lpad,h_256,w_256,f_auto,q_auto:eco,dpr_1/v1412734399/fyjokljdphznvooctkwi.png?resize=154%2C152&ssl=1",
            "https://i0.wp.com/res.cloudinary.com/crunchbase-production/image/upload/c_lpad,h_256,w_256,f_auto,q_auto:eco,dpr_1/v1401446145/uwo7mok7ouwkhuplbrmr.jpg?resize=154%2C152&ssl=1",
            "https://res.cloudinary.com/crunchbase-production/image/upload/c_thumb,h_256,w_256,f_auto,g_faces,z_0.7,q_auto:eco,dpr_1/kf6hm1lmhu03hztxzdrj",
            "https://res.cloudinary.com/crunchbase-production/image/upload/c_thumb,h_256,w_256,f_auto,g_faces,z_0.7,q_auto:eco,dpr_1/stigqs844r5jgp0ewspq",
            "https://i0.wp.com/res.cloudinary.com/crunchbase-production/image/upload/c_lpad,h_256,w_256,f_auto,q_auto:eco,dpr_1/v1505465185/ptwzxwk8vefgjikrx2uj.png?resize=154%2C152&ssl=1",
            "https://i0.wp.com/res.cloudinary.com/crunchbase-production/image/upload/c_lpad,h_256,w_256,f_auto,q_auto:eco,dpr_1/v1426161583/myb2pzh97lbeqrdoz5k0.png?resize=154%2C152&ssl=1",
            "https://res.cloudinary.com/crunchbase-production/image/upload/c_lpad,h_256,w_256,f_auto,q_auto:eco,dpr_1/roipvxqxadi6wnji0fh9",
            "https://i0.wp.com/res.cloudinary.com/crunchbase-production/image/upload/c_thumb,h_256,w_256,f_auto,g_faces,z_0.7,q_auto:eco,dpr_1/v1398453751/kb3lyoakokbiahlpktbg.png?resize=154%2C152&ssl=1",
            "https://res.cloudinary.com/crunchbase-production/image/upload/c_lpad,h_256,w_256,f_auto,q_auto:eco,dpr_1/b4q0qvgbxybkyt8xdvam",
            "https://i0.wp.com/res.cloudinary.com/crunchbase-production/image/upload/c_lpad,h_256,w_256,f_auto,q_auto:eco,dpr_1/v1469084952/t8dxycejukfrejqpz2xi.png?resize=154%2C152&ssl=1",
            "https://i0.wp.com/res.cloudinary.com/crunchbase-production/image/upload/c_thumb,h_256,w_256,f_auto,g_faces,z_0.7,q_auto:eco,dpr_1/v1471975459/ivbavqparzafunqu4czn.jpg?resize=154%2C152&ssl=1",
            "https://i0.wp.com/res.cloudinary.com/crunchbase-production/image/upload/c_lpad,h_256,w_256,f_auto,q_auto:eco,dpr_1/v1499346612/zeh9ya2e6q3dergqvggi.jpg?resize=154%2C152&ssl=1",
            "https://i0.wp.com/res.cloudinary.com/crunchbase-production/image/upload/c_thumb,h_256,w_256,f_auto,g_faces,z_0.7,q_auto:eco,dpr_1/v1479892692/juynrmrhbavel8sogihb.jpg?resize=154%2C152&ssl=1",
            "https://res.cloudinary.com/crunchbase-production/image/upload/c_lpad,h_256,w_256,f_auto,q_auto:eco,dpr_1/eobm5n8yxavqhrgs4yyk",
            "https://i0.wp.com/res.cloudinary.com/crunchbase-production/image/upload/c_thumb,h_256,w_256,f_auto,g_faces,z_0.7,q_auto:eco,dpr_1/v1460655461/qw8isqs597fumakj5pqb.jpg?resize=154%2C152&ssl=1",
            "https://res.cloudinary.com/crunchbase-production/image/upload/c_lpad,h_256,w_256,f_auto,q_auto:eco,dpr_1/inw5z64aiksuugu42dxc",
            "https://i0.wp.com/res.cloudinary.com/crunchbase-production/image/upload/c_thumb,h_256,w_256,f_auto,g_faces,z_0.7,q_auto:eco,dpr_1/v1397184197/8368261b389f4240a210a8c38087cf2c.jpg?resize=154%2C152&ssl=1",
            "https://res.cloudinary.com/crunchbase-production/image/upload/c_thumb,h_256,w_256,f_auto,g_faces,z_0.7,q_auto:eco,dpr_1/kj7gf4baahx3wii33w0d",
            "https://i0.wp.com/res.cloudinary.com/crunchbase-production/image/upload/c_thumb,h_256,w_256,f_auto,g_faces,z_0.7,q_auto:eco,dpr_1/v1419620800/z20dgiglx1nthzzgimqk.jpg?resize=154%2C152&ssl=1",
            "https://i0.wp.com/res.cloudinary.com/crunchbase-production/image/upload/c_lpad,h_256,w_256,f_auto,q_auto:eco,dpr_1/v1423034096/hh05tdvre9zmyxktp8x2.png?resize=154%2C152&ssl=1",
            "https://i0.wp.com/res.cloudinary.com/crunchbase-production/image/upload/c_thumb,h_256,w_256,f_auto,g_faces,z_0.7,q_auto:eco,dpr_1/v1497538310/rttskfg32bnqneqqugok.png?resize=154%2C152&ssl=1",
            "https://i0.wp.com/res.cloudinary.com/crunchbase-production/image/upload/c_lpad,h_256,w_256,f_auto,q_auto:eco,dpr_1/v1471414341/cqf7ogcp2ibgxjynz0ax.png?resize=154%2C152&ssl=1",
            "https://res.cloudinary.com/crunchbase-production/image/upload/c_lpad,h_256,w_256,f_auto,q_auto:eco,dpr_1/flonvjl0pwhiratzhpk0",
            "https://i0.wp.com/res.cloudinary.com/crunchbase-production/image/upload/c_lpad,h_256,w_256,f_auto,q_auto:eco,dpr_1/v1490146232/mk9pqkelxfgii7jtvqsg.png?resize=154%2C152&ssl=1",
            "https://i0.wp.com/res.cloudinary.com/crunchbase-production/image/upload/c_thumb,h_256,w_256,f_auto,g_faces,z_0.7,q_auto:eco,dpr_1/v1495345155/d1gechz934xd8uqmie5h.png?resize=154%2C152&ssl=1",
            "https://res.cloudinary.com/crunchbase-production/image/upload/c_lpad,h_256,w_256,f_auto,q_auto:eco,dpr_1/muyu4zgghn0azqfpmm4l",
            "https://res.cloudinary.com/crunchbase-production/image/upload/c_lpad,h_256,w_256,f_auto,q_auto:eco,dpr_1/cssvsoqkv3g35m4egxmw",
            "https://i0.wp.com/res.cloudinary.com/crunchbase-production/image/upload/c_thumb,h_256,w_256,f_auto,g_faces,z_0.7,q_auto:eco,dpr_1/v1505468834/r0miaasho7swnbb28rmv.jpg?resize=154%2C152&ssl=1",
            "https://i0.wp.com/res.cloudinary.com/crunchbase-production/image/upload/c_lpad,h_256,w_256,f_auto,q_auto:eco,dpr_1/v1457927379/euitlhvjdqeb506ufe1v.png?resize=154%2C152&ssl=1",
            "https://res.cloudinary.com/crunchbase-production/image/upload/c_lpad,h_256,w_256,f_auto,q_auto:eco,dpr_1/gjbyznxjpmvqszlgu9nl",
            "https://res.cloudinary.com/crunchbase-production/image/upload/c_lpad,h_256,w_256,f_auto,q_auto:eco,dpr_1/rp5evzrcqa6iva6wv4na",
            "https://res.cloudinary.com/crunchbase-production/image/upload/c_lpad,h_256,w_256,f_auto,q_auto:eco,dpr_1/pgea0bbawugwxm5bfqfx",
            "https://i0.wp.com/res.cloudinary.com/crunchbase-production/image/upload/c_lpad,h_256,w_256,f_auto,q_auto:eco,dpr_1/v1456698848/vhyisudmjflra0m46nbc.jpg?resize=154%2C152&ssl=1",
            "https://i0.wp.com/res.cloudinary.com/crunchbase-production/image/upload/c_thumb,h_256,w_256,f_auto,g_faces,z_0.7,q_auto:eco,dpr_1/v1397189186/51fe58279bfccdea063eacee8beac2d3.jpg?resize=154%2C152&ssl=1",
            "https://i0.wp.com/res.cloudinary.com/crunchbase-production/image/upload/c_thumb,h_256,w_256,f_auto,g_faces,z_0.7,q_auto:eco,dpr_1/v1465761866/vzkoyw1bispcfibjnwxl.jpg?resize=154%2C152&ssl=1",
            "https://i0.wp.com/res.cloudinary.com/crunchbase-production/image/upload/c_thumb,h_256,w_256,f_auto,g_faces,z_0.7,q_auto:eco,dpr_1/v1503699854/vegselnrrfkjvowmkxri.png?resize=154%2C152&ssl=1",
            "https://i0.wp.com/res.cloudinary.com/crunchbase-production/image/upload/c_lpad,h_256,w_256,f_auto,q_auto:eco,dpr_1/v1447327515/hfjsdyhzbj8yxkshw2al.png?resize=154%2C152&ssl=1",
            "https://res.cloudinary.com/crunchbase-production/image/upload/c_thumb,h_256,w_256,f_auto,g_faces,z_0.7,q_auto:eco,dpr_1/e6iuvbge3l7p8myqra9o",
            "https://res.cloudinary.com/crunchbase-production/image/upload/c_lpad,h_256,w_256,f_auto,q_auto:eco,dpr_1/ul5sth30lcenyaarqh34",
            "https://res.cloudinary.com/crunchbase-production/image/upload/c_thumb,h_256,w_256,f_auto,g_faces,z_0.7,q_auto:eco,dpr_1/ymsktkhk9sl39kp4ohss",
            "https://res.cloudinary.com/crunchbase-production/image/upload/c_thumb,h_256,w_256,f_auto,g_faces,z_0.7,q_auto:eco,dpr_1/z9ahyk9oiccwngkwrtlc",
            "https://i0.wp.com/res.cloudinary.com/crunchbase-production/image/upload/c_lpad,h_256,w_256,f_auto,q_auto:eco,dpr_1/v1409023436/sk1cfmpfo5y7rnas6wuk.jpg?resize=154%2C152&ssl=1",
            "https://res.cloudinary.com/crunchbase-production/image/upload/c_lpad,h_256,w_256,f_auto,q_auto:eco,dpr_1/rr5g9px74v9vxiio0l8j",
            "https://res.cloudinary.com/crunchbase-production/image/upload/c_lpad,h_256,w_256,f_auto,q_auto:eco,dpr_1/kljfpznhkv6gjey6a5ml",
            "https://res.cloudinary.com/crunchbase-production/image/upload/c_lpad,h_256,w_256,f_auto,q_auto:eco,dpr_1/i9a2wrwuwpcs3dwp09gl",
            "https://res.cloudinary.com/crunchbase-production/image/upload/c_thumb,h_256,w_256,f_auto,g_faces,z_0.7,q_auto:eco,dpr_1/up3sxaf7zc7z9dgmhwy3",
            "https://res.cloudinary.com/crunchbase-production/image/upload/c_lpad,h_256,w_256,f_auto,q_auto:eco,dpr_1/gugexida3hslzfzst3sn",
            "https://i0.wp.com/res.cloudinary.com/crunchbase-production/image/upload/c_thumb,h_256,w_256,f_auto,g_faces,z_0.7,q_auto:eco,dpr_1/v1476126868/ryyuetm1mc1xpmgqvits.png?resize=154%2C152&ssl=1",
            "https://i0.wp.com/res.cloudinary.com/crunchbase-production/image/upload/c_lpad,h_256,w_256,f_auto,q_auto:eco,dpr_1/v1497519987/yjpnkatjbez4ezwzj9dz.png?resize=154%2C152&ssl=1",
            "https://res.cloudinary.com/crunchbase-production/image/upload/c_thumb,h_256,w_256,f_auto,g_faces,z_0.7,q_auto:eco,dpr_1/dokhrlbzwx0tqoijao4q",
            "https://res.cloudinary.com/crunchbase-production/image/upload/c_thumb,h_256,w_256,f_auto,g_faces,z_0.7,q_auto:eco,dpr_1/arpzpryiiyjwj3xaiowt",
            "https://i0.wp.com/res.cloudinary.com/crunchbase-production/image/upload/c_thumb,h_256,w_256,f_auto,g_faces,z_0.7,q_auto:eco,dpr_1/v1469563287/isgjraeck8piywm9lpeo.jpg?resize=154%2C152&ssl=1",
            "https://secure.gravatar.com/avatar/abd2f6a5c013f56b5e33251960f50fe1?s=300&d=mm&r=g",
            "https://i0.wp.com/beststartup.us/wp-content/uploads/2023/11/BEST-STARTUP.US-LOGO.png?fit=854%2C130&ssl=1",
            "https://i0.wp.com/beststartup.us/wp-content/uploads/2023/11/john-schnobrich-FlPc9_VocJ4-unsplash.jpg?resize=150%2C150&ssl=1",
            "https://i0.wp.com/beststartup.us/wp-content/uploads/2023/05/Best-US-Cover.png?resize=150%2C150&ssl=1",
            "https://i0.wp.com/beststartup.us/wp-content/uploads/2022/10/Best-US-Cover-1.png?resize=150%2C150&ssl=1"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [
            "Best Startup"
        ],
        "publish_date": "2022-05-12T11:03:49+00:00",
        "summary": "",
        "meta_description": "Top Companies (Navigation) show 1 Othman Laraki 2 Varsha Rao 3 James Park 4 Sherri Douville 5 Anthony P Mack 6 Lin Jixun 7 Shannon Ralston 8 Adam Karp 9 Gwyneth Paltrow 10 Laurence Girard 11 Harpreet Rai 12 George Archos 13 Paul Black 14 April Koh 15 Naveen Jain 16 Saeju Jeong 17 Jessica Richman 18 Yi Liu 19 David Ko 20 Felix Bustos III 21 Zachariah Reitano 22 Eric Moskow 23 Eric Marcotulli 24 Alessandra Lezama 25 Stephanie Tilenius 26 Anil Sethi 27 Patrick Nagle 28 Ed Park 29 Dustin DeVan 30 Aaron Kaufman 31 Alyson Watson 32",
        "meta_lang": "en",
        "meta_favicon": "https://i0.wp.com/beststartup.us/wp-content/uploads/2021/05/cropped-StartupUS-favicon-1.png?fit=32%2C32&ssl=1",
        "meta_site_name": "Best Startup US",
        "canonical_link": "https://beststartup.us/meet-united-statess-101-top-ceos-in-the-health-care-space/",
        "text": "Othman Laraki\n\nCo-founder & CEO of Color\n\nOthman Laraki, MS, MBA, is the Co-founder and Chief Executive Officer of Color, a health technology company building public health infrastructures such as scaled and efficient testing to contain the COVID-19 pandemic or using genomics for population health. Previously, Othman co-founded Mixer Labs and developed its GeoAPI platform, a powerful location engine for developers. After the company was acquired by Twitter in 2009, he served as the social media network’s Vice President of Product and helped expand its user base from 50 to 200 million unique accounts. Before this, Othman spent several years at Google, where he played an integral role developing front-end products, including the Chrome browser. Othman is a long-time investor and advisor to leading companies such as Pinterest, AngelList, Slack and Instacart, and serves as a board member for ESI Group and Frontier Medicines. He holds degrees in computer science and management from Stanford University and the Massachusetts Institute of Technology.\n\nFollow Othman Laraki:\n\nCrunchbase\n\nLinkedin\n\nAbout Color: Color is a population health technology company that enables the delivery of advanced healthcare through clinical genetics.\n\nWebsite\n\nCrunchbase\n\nLinkedin\n\nVarsha Rao\n\nChief Executive Officer of Nurx\n\nVarsha Rao is the CEO of Nurx, which is revolutionizing healthcare by home-delivering prescriptions, medication, and screening tests. She is a Board Member at ViaSat Inc., and the former COO of Clover Health, a health insurance startup developing an innovative platform that collects and analyzes long-term medical data to improve the health management and wellbeing of its clients. Varsha previously served as Head of Global Operations at Airbnb, where she was responsible for managing 16 offices across the globe and leading the company’s customer service and trust and safety teams in Oregon, Portland, Singapore, Dublin and San Francisco. Under her leadership, the company’s operations in Asia expanded, with many new hosts and visitors joining the Airbnb family. However, her entrepreneurial journey began much earlier, in 1998 when she founded Eve.com together with Mariam Naficy. Eve.com quickly became the leading e-commerce retailer for beauty and accessories. Within two years the company grew to 125 employees. Eve.com was sold to Idealab in early 2000 for $110M. In 1999, Fortune Magazine named the company as the 6th Best e-commerce site. Between founding Eve.com and landing at Airbnb, Rao has held a variety of senior roles. She was appointed VP, Category Marketing at Keen/Ingenio (acquired by AT&T) in 2001 and managed P&L for new and emerging major categories. In 2004-2008, she was VP, General Manager for OldNavy.com, the online division of Gap, Inc., where she led the company’s product development, marketing and merchandising efforts, resulting in a 60% increase in revenues. Rao went on to join SingTel as CEO, Digital Media in 2008 and led the team to launch its local search & reviews business inSing.com. After 3 years at SingTel she left to become Senior Vice President, International for LivingSocial where she was the first LivingSocial employee in Asia. As Senior VP, Rao managed more than 2,000 employees in the company’s network of offices in Asia, Australia, New Zealand, Latin America and Europe. Varsha is a Sequoia Capital Scout, and a mentor for the KStart Catalyst, an incubator and seed investment program for early stage startups in India. She herself has also invested in several startups in various fields including e-commerce, finance and renewable energy. In 2014, she was named by San Francisco Business Times as one of the ‘Most Influential Business Women’ in the Bay Area and in 2016 she featured in The Boardlist’s top 20 list of women every Silicon Valley tech company should be adding to their board. Rao received her BS/BA in Economics/Math from the University of Pennsylvania. For two years following graduation, she worked at the Wasserstein Perella financial consulting firm, where she advised clients on private and public investment strategies. She then returned to school to obtain an MBA from Harvard Business School. As a strong believer in the power of education she contributes to a variety of educational initiatives for underprivileged children and youth. Among them Breakthrough, a program that works to motivate and empower K12 students to continue to higher education and excel academically and professionally.\n\nFollow Varsha Rao:\n\nCrunchbase\n\nLinkedin\n\nAbout Nurx: Nurx is a digital healthcare company offering 10 services across reproductive health, at-home testing, dermatology, migraine care, and more.\n\nWebsite\n\nCrunchbase\n\nLinkedin\n\nSherri Douville\n\nChief Executive Officer of Medigram\n\nSherri Douville is CEO & Board Member at Medigram and is a sought-after speaker and author in mobile medical technology, other healthcare related industries, leadership, risk management, mobile security, and governance. Ms. Douville is honored to strategically build, grow, and lead multi-disciplinary, multi industry teams at Medigram and in the market to solve the leading cause of preventable death –a delay in information. Ms. Douville is co-chair of the technical trust and identity standard subgroup for the healthcare industry for clinical IoT through IEEE and UL and has been published and quoted in both mainstream and industry media such as CIO.com, the San Jose Mercury News, NBC, Becker’s Hospital Review, ThisWeekinHealthIT and HITInfrastructure.com. Other industry leadership has included serving on the board of the NorCal HIMSS and teaching continuing education credit in mobile security for CISSP, the information security certification. She is co-author for a number of technical articles and papers, a forthcoming Springer book chapter on Engineering Trust in Clinical IoT and is the lead author and editor for the #1 hottest new release in medical technology and medical informatics on Amazon, and the #1 BookAuthority ebook in the world for healthcare in 2021, Mobile Medicine: Overcoming People, Culture, and Governance (Taylor & Francis). Ms. Douville led the development of this industry guide to mobile computing in medicine and built the international, multi industry, multi disciplinary team behind it. Prior to her current work in the mobile medicine, privacy, security, health IT and AI industries, Sherri worked in the medical device space consulting in the areas of physician acceptance and economic feasibility for medical devices. Prior to that, she worked for over a decade with products addressing over a dozen disease states at Johnson & Johnson and was recognized for industry thought leadership there by McGraw-Hill and won a number of awards. Ms. Douville has a Bachelor of Combined Science degree from Santa Clara University and has completed certificates in electrical engineering, computer science, AI and ML through MIT. She advises and serves startups, boards, and organizations including as a member of the Board of Fellows for Santa Clara University and an advisor to the Santa Clara University Leavey School of Business Corporate Board Education initiatives, the Black Corporate Board Readiness Program, LatinX Corporate Board Readiness Program and an advisory board member to the Women’s Corporate Board Readiness Program.\n\nFollow Sherri Douville:\n\nCrunchbase\n\nLinkedin\n\nAbout Digital Directors Network, Medigram, Taylor & Francis Group: Medigram provides instant insight to save lives and make hospitals millions on iOS, Android, & the web. It is a full stack system.\n\nWebsite\n\nCrunchbase\n\nLinkedin\n\nAdam Karp\n\nCo-Founder & CEO of Lively\n\nPrior to Lively, Adam was the Chief Marketing Officer of 1stdibs – the world’s premier destination for unique, luxury design. At 1stdibs, Adam was instrumental in increasing the company’s revenue almost 10x; recruited and led a team of 100 and had full P&L responsibility for 1stdibs’ B2B business. Before 1stdibs Adam worked in senior roles at leading brands such as FreshDirect, Barnes & Noble and Century 21 real estate. At Century 21 he was responsible for developing and launching Century 21’s first website which at the time became the most recognized real estate website in the country and currently generates almost 50 million visits a year. After Century 21, Adam spent almost a decade at Barnes & Noble in increasingly senior roles ultimately becoming VP of Direct Marketing for both the retail stores and online. At Barnes & Noble, Adam managed some of the largest digital marketing programs in the industry, overseeing a budget of $100M. Adam graduated from the The Wharton School at the University of Pennsylvania with a degree in Economics.\n\nFollow Adam Karp:\n\nCrunchbase\n\nLinkedin\n\nAbout Lively: Lively’s mission is to democratize, simplify and de-stigmatize the adoption and use of technically advanced hearing aids.\n\nWebsite\n\nCrunchbase\n\nLinkedin\n\nLaurence Girard\n\nCEO & Founder of Fruit Street\n\nLaurence Girard is the CEO and Founder of Fruit Street which is the first company to deliver the CDCs National Diabetes Prevention Program via telehealth and live video conferencing with registered dietitians. The company had raised more than $20 million in funding from approximately 300 physician investors. Laurence graduated from the Harvard Extension School with a Bachelor’s Degree. His passion for entrepreneurship started during his first year of college when the Harvard Innovation Lab was opened in the Harvard Business School campus. While in college, Laurence was volunteering in an emergency room while taking a nutrition epidemiology course. It was at this point he decided our healthcare system needed to focus more on prevention and that he decided to focus his career in public health, technology, and entrepreneurship. Laurence is also the Managing Director of Hippocrates Ventures, a physician funded VC fund. His company Fruit Street recently launched COVIDMD.com, a new national telemedicine service battling the COVID-19 pandemic.\n\nFollow Laurence Girard:\n\nCrunchbase\n\nLinkedin\n\nAbout Fruit Street, Hippocrates Ventures, New Amsterdam Football Club: Fruit Street is a developer of a digital diabetes prevention and weight loss program.\n\nWebsite\n\nCrunchbase\n\nLinkedin\n\nGeorge Archos\n\nCo-Founder, Chairman and CEO of Verano Holdings\n\nGeorge Archos is the founder & CEO of Verano Holdings. He is a logistics and operations guru. Building on his extensive experience in coordinating complex freight delivery operations, as well as designing and operating highly-successful restaurants, George entered the cannabis industry in 2014 when he founded Ataraxia Grow and Labs in Illinois and was the first to receive authorization to grow medical cannabis out of 21 recipients of the coveted medical licenses. George’s diligence, perseverance, and tireless work ethic have made him one of the cannabis industry’s most successful entrepreneurs. Leveraging his unparalleled devotion to quality and a unique results-oriented approach to the cannabis industry, George has overseen the development of some of cannabis’s most highly-coveted operations and brands. George’s restaurants across the Chicagoland area, including Wildberry Pancakes & Café, Westwood Tavern & Tap and the Scout Waterhouse & Kitchen, all bear the imprint of his relentless devotion to quality and unrivaled customer service, earning him multiple awards and recognition. George’s unique experience, his admirable drive, and his unrelenting commitment to quality, coupled with his capacity to establish, build, and effectively run multi-jurisdictional companies, are an asset to Verano Holdings.\n\nFollow George Archos:\n\nCrunchbase\n\nLinkedin\n\nAbout Verano Holdings: Verano is a vertically integrated, multi-state cannabis operator.\n\nWebsite\n\nCrunchbase\n\nLinkedin\n\nNaveen Jain\n\nFounder & CEO of Viome\n\nNaveen Jain is an entrepreneur and philanthropist driven to solve the world’s biggest challenges through innovation. He is the founder of several successful companies including Moon Express, BlueDot, Viome, Intelius, TalentWise and InfoSpace. Moon Express is the only company to have permission from the US government to leave earth orbit and land on the moon. It’s developing technologies to harvest planetary resources on the moon for the benefit of humanity. BlueDot is focused on bringing most promising technological innovations from the national labs, NASA and elite universities and supercharging them with great entrepreneurs to create successful enterprises that tackle humanity’s grand challenges. Viome is focused on discovering predictive biomarkers to eradicate all diseases. Our initial goal is to provide personalized diet & nutrition based on deep analysis of microbiome, metabolome and meta genomics. Naveen Jain a trustee of the board and vision circle member at the X PRIZE Foundation where he is focused on finding entrepreneurial solutions to address the global challenges in health, education, women empowerment, agriculture, and energy. Naveen Jain is on the board of Singularity University, an interdisciplinary university with the mission to educate and inspire leaders to address humanity’s grand challenges through innovative technologies. Naveen Jain has been awarded many honors for his entrepreneurial successes and leadership skills including “Ernst & Young Entrepreneur of the Year”, “Albert Einstein Technology Medal” for pioneers in technology, “Humanitarian Innovation Award” at the United Nations, “Distinguished Global Thinker Award” by IILM, “Most inspiring Entrepreneur” by Andaaz TV, “Most admired Serial Entrepreneur” by Silicon India, “Top 20 Entrepreneurs” and “Lifetime Achievement Award” for the leadership in the technology industry and support of other entrepreneurs by Red Herring.\n\nFollow Naveen Jain:\n\nCrunchbase\n\nLinkedin\n\nAbout Bellevue LifeSpring, BlueDot, Moon Express, TalentWise, Viome, World Innovation Inc: Viome is a provider of comprehensive health insights designed to help people track their gut microbiome health.\n\nWebsite\n\nCrunchbase\n\nLinkedin\n\nJessica Richman\n\nCo Founder & CEO of uBiome\n\nJessica Richman is the co-founder and CEO of uBiome, a startup that uses big data and citizen science to understand the human microbiome. Jessica started and sold her first company after high school. Returning to formal education, she attended Stanford University, where she earned degrees in Economics and Science, Technology & Society (interdisciplinary engineering, emphasis in computer science). Along the way, she worked for Google, McKinsey, Lehman Brothers, the Grameen Bank, and top-tier Silicon Valley venture firms as well as other entrepreneurial projects and adventures. Her work has been published in The New York Times and other national publications. Jessica arrived at Oxford University as a Clarendon Scholar and completed an MSc at the Oxford Internet Institute. Currently a Green Templeton DPhil Scholar, her academic interests include network analytics, innovation, and collective intelligence. Her work has been featured in Wired, MIT Technology Review, Scientific American, NPR, FoxNews, ABC News, and dozens of other media outlets. She has spoken at TEDMED, TEDxBrussels, Partnering for Cures, the American Society for Microbiology, HealthFoo, SciFoo, Oxford University, the University of California San Francisco, and many other conferences and venues.\n\nFollow Jessica Richman:\n\nCrunchbase\n\nLinkedin\n\nAbout uBiome: uBiome is a provider of public access to DNA sequencing technology to understand the microbiome.\n\nWebsite\n\nCrunchbase\n\nLinkedin\n\nDavid Ko\n\nCo-founder and CEO of Ripple Health Group\n\nDavid Ko is the Co-founder and CEO of Ripple Health Group (RHG), an early stage healthtech startup focused on helping people experience healthier lives by connecting them to the care, support, and community they need. Prior to RHG, David was the President, COO and Board Member of Rally Health, a digital health company that develops online and mobile solutions that make it easy for consumers to take charge of their health and health care. Rally’s solutions are currently available to nearly 55 million people through health plans, care providers, and more than 200,000 employers. Prior to joining Rally, David oversaw all strategy, planning and operations as COO at Zynga, which he helped take public in December 2011. At the time of its IPO, Zynga was the largest social gaming company in the world with over 100 million daily active users. Prior to his work at Zynga, he spent 10 years at Yahoo! in various senior executive roles, including SVP of Yahoo!’s audience, mobile, and local businesses. David serves on the board of overseers at his alma mater New York University Stern School of Business where in 2016 he established the NYU Stern Venture Fellows program for aspiring entrepreneurs. He also works as an advisor and investor to a number of companies in Silicon Valley including Calm, the number one app for Sleep, Meditation and Relaxation.\n\nFollow David Ko:\n\nCrunchbase\n\nLinkedin\n\nAbout Audax Health Solutions, Calm, Ripple Health Group: Ripple Health Group is a platform for the world’s most trusted healthcare solutions.\n\nWebsite\n\nCrunchbase\n\nLinkedin\n\nFelix Bustos III\n\nCo-Founder & CEO of ZB Technologies, Inc.\n\nFelix is passionate about using emerging technologies and inspiring others to prevent cancer. His purpose in life is to help end cancer. After losing his mother, sister, niece, and two cousins to cancer, he committed to the mission of winning the fight against cancer through artificial intelligence, emerging technologies, precision nutrition, and preventive healthcare. During the Fall of 2019, Felix, together with a team of software developers, engineers, data scientists, and physicians, soft-launched HelenHealth.co, a digital health platform that connects people with the best oncology healthcare resources. While in graduate school he conducted research on artificial intelligence and developed a machine learning model for digital health platforms. The venture was developed at the Harvard Innovation Labs’ Venture Incubation Program and accelerated through Harvard Medical School’s Healthcare Innovation & Commercialization Fall 2020 cohort, as the team relentlessly synergizes new approaches to solving the cancer problem. The venture’s long-term vision is, to connect a global Digital Health Ecosystem with the best resources available for everyone to live a disease-free life. Prior to co-founding a health technology company, Felix spent more than a decade in leadership and senior-level positions at Fortune 500 and high technology startup companies. At Virgin Galactic (NYSE: SPCE), he was part of the early R&D team that conceptualized an air-launched rocket, LauncherOne, prior to the project spinning off to Virgin Orbit (NASDAQ: VORB). He was also an early-stage team member at The Spaceship Company, which worked on SpaceShipTwo and a hybrid rocket engine. While at BAE Systems, he was part of an air-launch space transportation system team, now Paul Allen’s Stratolaunch. He started his R&D career at Lockheed Martin Skunk Works (NYSE: LMT). Felix was also on active duty in the U.S. Air Force and serves in the U.S. Coast Guard Reserve, as a joint staff officer, and is currently a reserve officer at the Defense Innovation Unit in Mountain View, California, providing technical/scientific expertise within the Space and Human Systems portfolios, and is the reserve lead for Artificial Intelligence. Awardee in The Top 100 Harvard Alumni in Technology of 2021.\n\nFollow Felix Bustos III:\n\nCrunchbase\n\nLinkedin\n\nAbout ZB Technologies, Inc.: We’re a Health Technology company passionate about ending cancer by providing everyone with the best healthcare ecosystem.\n\nWebsite\n\nCrunchbase\n\nLinkedin\n\nEric Moskow\n\nChief Executive Officer, Director of Accuity Delivery Systems\n\nFounder, CEO and Executive of several highly successful healthcare ventures; including DDDS, OBDS, and Cybear. Dr. Moskow is recognized as an innovative leader in the efficient operation of medical practices. He formed Outcome Based Delivery Systems, with operations in South Florida, Orlando, Florida and Las Vegas, Nevada, which OBDS sold in October 2011. From its founding in 2006 through the sale of its operations, OBDS built its revenue base from a run rate of $0 in 2006 to more than $80M in 2011. He formed Coral Gate Medical Group, a medical practice in Broward County, Florida, in January 2002 and has operated as its Managing Partner since inception. From 2002 to 2005, Coral Gate’s revenues increased from $350,000 to $3.5 million. From February 2000 through January 2002, Dr. Moskow served as Executive Vice President of Cybear, an information technology company serving the health care industry formed by Andrx Corp. He served as a Director of Cybear from June 1999 to 2002. From September 1996 to January 2000, Dr. Moskow was Executive Vice President of Strategic Planning for Phymatrix, a publicly-traded multi-specialty medical provider network. In addition, during this period and then through March 2002, he served as a Director of Phymatrix and its successor, Innovative Clinical Solutions, Ltd. (“ICSL”). From 1989 to 1997, Dr. Moskow served as an Internist and President of Family Medical Associates in Ridgefield, Connecticut. During part of this same period, from October 1995 to October 1996, Dr. Moskow served as Executive Vice President of Physician’s Choice Management, LLC (“PCM”), which he co-founded. In addition, from 1988 to 1992, Dr. Moskow served as Associate Medical Director in Connecticut for U.S. Healthcare. Dr. Moskow is board certified in internal medicine. He received his B.S. degree from Vassar College in 1980 and his M.D. degree from New York Medical College in 1984.\n\nFollow Eric Moskow:\n\nCrunchbase\n\nLinkedin\n\nAbout Accuity Delivery Systems: Accuity Delivery Systems is a provider of clinical documentation services for the healthcare industry.\n\nWebsite\n\nCrunchbase\n\nLinkedin\n\nAlessandra Lezama\n\nCEO of TOOTRiS\n\nAlessandra Lezama is an entrepreneur and PE backed CEO, advocate for women pursuing careers in tech and other STEM fields, angel investor to San Diego-based early-stage companies and Founder and CEO of TOOTRiS, an on-demand Child Care technology platform that is reinventing how parents access and pay for affordable, high-quality Child Care. Passionate about technology, Alessandra has enjoyed an illustrious career of taking underperforming tech companies and turning them into scalable, high-performance powerhouses. Prior to founding TOOTRiS, Alessandra was the CEO for multiple technology companies, including AbacusNext, a San Diego-based company she stepped into with 29 employees and, in less than four years, transformed into a disruptive global technology organization with more than 500 employees across San Diego, Canada and the United Kingdom. Companies under Alessandra’s leadership have been recognized in Forbes and Inc., and in 2016 and 2017 she was named “Women Who Mean Business,” in 2018 as “Most Admired CEO of the Year” and in 2019 as “Most Influential” by the San Diego Business Journal. Alessandra is a member of the San Diego Regional Chamber of Commerce, serving on its board and management council. She serves on the board of Doors of Change, a non-profit that is helping to break the cycle and save the lives of runaway, homeless, and trafficked young people. She is a member of the California Preschool Business Advisory Council, supporting efforts to produce viable policy for high quality early education that gives a competitive edge for California’s businesses, both immediately and the future.\n\nFollow Alessandra Lezama:\n\nCrunchbase\n\nLinkedin\n\nAbout TOOTRiS: TOOTRiS is a technology platform that allows parents affordable access to high-quality Child Care, anytime, anywhere.\n\nWebsite\n\nCrunchbase\n\nLinkedin\n\nRaja Dhir\n\nCo-Founder and Co-CEO of Seed Health\n\nRaja Dhir is a life sciences entrepreneur and Co-Founder of Seed Health, a venture-backed microbiome company pioneering the application of bacteria for both human and planetary health. He leads Seed’s R&D, academic collaborations, technology development, clinical trial design, supply chain, and intellectual property strategy. Together with Dr. Jacques Ravel, he Co-Chairs Seed’s Scientific Advisory Board–an interdisciplinary group of scientists and doctors who lead research teams and teach at institutions including the teaching hospital of Harvard Medical School and the Trial Innovation Unit of Mass. General Hospital (MGH). Raja has designed clinical trials with leading academic institutions including the teaching hospital of Harvard Medical School and the Trial Innovation Unit of Mass. General Hospital (MGH). Raja has unique expertise translating scientific research for product development with a track record that includes patented inventions to stabilize sensitive compounds to improve alpha-diversity of the gut microbiome (derived from micro-algae) and most recently, the co-invention of microbial technologies to protect honeybee populations (Apis mellifera) from neonicotinoid pesticides and pathogen colonization. His work also includes biofermentation and scale-up for both facultative and strict anaerobic organisms. Raja has negotiated multiple joint-ventures, strategic partnerships, technology transfer and licensing agreements with publicly traded companies (NYSE, LSE) and academic institutions (Harvard Medical School, UCLA). To date, entities he has co-founded own the rights to 15+ patents and research emerging from $25MM+ of non-dilutive funding over 10+ years from the Bill and Melinda Gates Foundation and National Institute of Health (NIH). Raja serves on the Editorial Board for the scientific journal, Microbiome. He is a member of the Microbiome Think Tank at Mass. General Hospital (MGH) and sits on the Advisory Committee for the International Scientific Association of Probiotics and Prebiotics (ISAPP). Raja is also a Director and Co-Chair of the Scientific Advisory Board for Micropia, a $20MM microbial ecology / education platform and the world’s first museum dedicated to microbes.\n\nFollow Raja Dhir:\n\nCrunchbase\n\nLinkedin\n\nAbout Seed Health: Seed Health is a microbial company that focuses on therapeutics, consumer health innovations, and environmental solutions.\n\nWebsite\n\nCrunchbase\n\nLinkedin\n\nAra Katz\n\nCo-Founder and Co-CEO of Seed Health\n\nAra Katz is the Co-Founder and Co-CEO of Seed Health, a microbial sciences company pioneering the application of bacteria to impact human and planetary health. She has worked at the intersection of technology, consumer, design, and media is now working to steward a new standard in probiotics and how science is communicated to change how we discern evidence from evangelism to make the most informed choices for our bodies, our health, and our world. Ara previously co-founded and served as CMO of mobile commerce marketplace, Spring (backed by LMVH, sold to ShopRunner), and was on the founding team of social commerce company, BeachMint (sold to Conde Nast), where she launched six direct-to-consumer, influencer subscription brands. She is an angel investor and advisor in companies such as mindbodygreen, Stadium Goods (recently sold to FarFetch), RXDefine, women’s healthcare startup, Mahmee, and new biomaterials company, C16. Ara has been a fellow at the MIT Media Lab’s Center for Future Storytelling and CCA’s Design MBA program, was named in Marie Claire’s “The New Guard: The 50 Most Influential Women in America”, listed on Business Insider’s “Silicon Alley Top 100” and “36 Rockstar Women in NYC Tech”, and Create + Cultivate’s 100 List for STEM.\n\nFollow Ara Katz:\n\nCrunchbase\n\nLinkedin\n\nAbout Seed Health: Seed Health is a microbial company that focuses on therapeutics, consumer health innovations, and environmental solutions.\n\nWebsite\n\nCrunchbase\n\nLinkedin\n\nThomas Joyce\n\nPresident & CEO of Danaher\n\nThomas Joyce is President and Chief Executive Officer of Danaher Corporation, a position he assumed in September 2014. Thomas is responsible for the company’s strategic vision and leads the development and growth of Danaher’s global science and technology portfolio. Thomas has more than 20 years of Danaher leadership experience. Prior to his appointment as President and Chief Executive Officer, he served as Executive Vice President of Danaher Corporation, responsible for Danaher’s Water Quality platform and Life Sciences & Diagnostics segment. In this role, Thomas increased Danaher’s Water Quality revenue by over $1.5 billion and led the company’s major acquisitions of Beckman Coulter and AB SCIEX. Throughout his tenure, Thomas has also played a key role in developing and evolving the Danaher Business System, Danaher’s common operating philosophy. Thomas began his Danaher career in 1989 as a Project Manager in the Danaher Tool Group, and later transitioned into a manufacturing role. In 1995, Thomas became President of Delta Consolidated Industries. Following this assignment, he became President of Hach Company, the world leader in analytical instrumentation for drinking water and wastewater applications in 2001. In 2002, Thomas became a Group Executive and Corporate Officer with Danaher Corporation, which led to his transition to Executive Vice President in 2006. Prior to joining Danaher, Thomas worked as a management consultant at Anderson Consulting, where he worked with a large number of manufacturing businesses to implement lean tools and optimize transactional processes. Thomas was born and raised on the north shore of Chicago and earned his bachelor’s degree in Economics from the College of the Holy Cross in 1982. He and his wife, Claire, live in Washington, D.C. and have four children.\n\nFollow Thomas Joyce:\n\nCrunchbase\n\nLinkedin\n\nAbout Danaher: Danaher is a global science and technology innovator committed to helping their customers solve complex challenges and improve quality.\n\nWebsite\n\nCrunchbase\n\nLinkedin\n\nBrenton Saunders\n\nChairman, President and Chief Executive Officer of Allergan\n\nBrent Saunders is Chief Executive Officer and President of Allergan plc (formerly Actavis plc). Brenton previously served as Chief Executive Officer and President of Forest Laboratories and had served as a Member of the Board of Directors at Forest since 2011. Brenton has significant healthcare industry expertise and a proven track-record leading business transformations and integrations. Prior to Forest, Brenton was Chief Executive Officer of Bausch + Lomb, a leading global eye health company, serving in this capacity from March 2010 until August 2013. Brenton also held a number of leadership positions at Schering-Plough, including the position of president of Global Consumer Health Care and was named head of integration for the company’s merger with Merck & Co. and for Schering-Plough’s acquisition of Organon BioSciences. Before joining Schering-Plough, Brenton was a Partner and Head of Compliance Business Advisory at PricewaterhouseCoopers LLP. Prior to that, Brenton was Chief Risk Officer at Coventry Health Care and Senior Vice President, Compliance, Legal and Regulatory at Home Care Corporation of America. Brenton began his career as Chief Compliance Officer for the Thomas Jefferson University Health System. Brenton serves on the Board of Trustees of the University of Pittsburgh. Brenton is also the former Chairman of the New York chapter of the American Heart Association. Brenton is a Member of the Business Council and PhRMA. Brenton earned his MBA from Temple University School of Business, his J.D. from Temple University School of Law and his Bachelor’s degree from the University of Pittsburgh.\n\nFollow Brenton Saunders:\n\nCrunchbase\n\nLinkedin\n\nAbout Allergan, Cisco: Allergan is a global pharmaceutical company.\n\nWebsite\n\nCrunchbase\n\nLinkedin\n\nSam Santhosh\n\nFounder Chairman & Global CEO of MedGenome\n\nSam Santhosh is the Founder and CEO of MedGenome. He has been an entrepreneur, with over 20 years of experience in the software industry. Currently, he is at the helm of affairs as CEO and promoter of MedGenome Labs Pvt Ltd. Sam sits on the board of a number of companies, both in the US and India. In this role he advises, guides and mentors companies to help them grow and realize their true potential. Prior to this Sam was the CEO and Managing Director of California Software Limited (Calsoft) from 1992 – Feb 2012. He founded Calsoft in 1992 and under Sam’s vision, Calsoft rapidly grew from a niche player in the Silicon Valley to a global player with over 1200 employees and presence in 8 countries. Sam took Calsoft Public and the company is listed the in Indian Stock Exchanges. Sam oversaw the growth of Calsoft in all key areas – Finance, Strategy, Customer Acquisition, and inorganic growth through eight acquisitions including companies in the U.S, UK, Japan, and India. He has been constantly retooling himself and has attended various training programs in different U.S universities including MIT. In 2010, he completed the Executive Education program at the Singularity University in Sunnyvale, California. Sam has an engineering degree and an MBA (majoring in Management Information Systems) from India’s premier institute, IIM Calcutta.\n\nFollow Sam Santhosh:\n\nCrunchbase\n\nLinkedin\n\nAbout Agrigenome, MedGenome: MedGenome develops a genomics-based diagnostics and research solution for healthcare providers to understand the genetic basis of diseases.\n\nWebsite\n\nCrunchbase\n\nLinkedin\n\nSylvana Quader Sinha\n\nFounder, Managing Director and CEO of Praava Health\n\nSylvana Q. Sinha is founder and CEO of Praava Health, a leading healthcare company focused on improving health outcomes and patient journeys in emerging markets, where 85% of the world lives but whose current systems typically prioritize profits over patients.\n\nSince launching in 2018, Praava has become Bangladesh’s fastest-growing consumer healthcare brand, and was designated a 2021 World Economic Forum Technology Pioneer and 2020 Fast Company World Changing Idea and Developing World Technology. Praava has served more than 300,000 patients and is tripling growth each year. Throughout the COVID-19 pandemic, Praava quadrupled its patient base while maintaining an NPS rating of 91.3—significantly exceeding even the highest scores of Fortune 500 companies.\n\nSylvana also has decades of experience leading teams in international law, business, development, and government relations at major international law firms, management consulting firms, the World Bank, and think tanks in the Middle East and S. Asia. In addition to serving as an advisor to then-Senator Obama, she has independently advised private and sovereign clients on investments, projects, and disputes in the Middle East, Africa, and S. Asia.\n\nSylvana is a Life Member of the Council on Foreign Relations, a member of the World Economic Forum’s UHC2030 Private Sector Constituency, and served on Mount Sinai’s Arnold Institute of Global Health Task Force for Global Advantage. She is a graduate of Columbia Law School, Harvard’s Kennedy School, and Wellesley College and was a Visiting Scholar at the University of Oxford.\n\nFollow Sylvana Quader Sinha:\n\nCrunchbase\n\nLinkedin\n\nAbout Praava Health: Praava Health is a patient-driven company disrupting the healthcare standard for Bangladesh’s 170 million citizens.\n\nWebsite\n\nCrunchbase\n\nLinkedin\n\nRobert C Robbins\n\nPresident and CEO of Texas Medical Center\n\nRobert C. Robbins became President and Chief Executive Officer of Texas Medical Center on November 5, 2012. Prior to that, he was professor and chairman of the Department of Cardiothoracic Surgery at Stanford University School of Medicine, where he served as a member of the faculty since 1993. He served as director of the Stanford Cardiovascular Institute, of the Heart- Lung and Lung Transplantation Programs, and of the Cardiothoracic Transplantation Laboratory. Dr. Robbins is an internationally recognized cardiac surgeon who has focused his clinical efforts on acquired cardiac diseases with a special expertise in the surgical treatment of congestive heart failure. His research work includes the investigation of stem cells for cardiac regeneration, cardiac transplant allograft vasculopathy, bioengineered blood vessels, and automated vascular anastomotic devices. He served as the guest editor of the Circulation Surgical Supplement from 2002 to 2005, president of the International Society of Heart and Lung Transplantation in 2006, president of the Bay Area Society of Thoracic Surgeons in 2006, chair of the American Heart Association Cardiovascular Surgery and Anesthesia Council from 2007 to 2009, councilor-at-large for the Western Thoracic Surgical Association from 2007 to 2009, and on the President’s Cabinet at California Polytechnic State University from 2006 to 2012. In California, he served on the Board of Directors for two publically traded companies, Cohesion Technologies from 2000 to 2003 and Cardica, Inc. from 2000 to2009, and as a director for several other privately held Bay Area biotechnology companies. In 2009, he was elected to the American Heart Association Western States Affiliate Board of Directors and currently serves as president of the organization. He was elected to the Board of Trustees of Millsaps College in Mississippi in 2010. Dr. Robbins has lectured widely and published more than 292 peer reviewed articles. He earned his bachelor’s degree in chemistry from Millsaps College in 1979 and a medical degree from the University of Mississippi in 1983. He completed his general surgical training at the University of Mississippi in 1989 and his cardiothoracic training at Stanford University in 1992. Dr. Robbins completed post-doctoral research at Columbia University and the National Institutes of Health, and congenital heart surgical fellowships at Emory University and Royal Children’s Hospital. An ex-officio of the Houston Livestock Show & Rodeo, Dr. Robbins currently sits on the Advisory Board of the Ronald McDonald House in Houston and on the Board of Directors for Texas Medical Center, the Greater Houston Partnership, the Greater Houston Convention and Visitors Bureau, the Houston Academy of Medicine Texas Medical Center Library, the Houston Technology Center, and the Friends of Houston Academy of Medicine Texas Medical Center Library.\n\nFollow Robert C Robbins:\n\nCrunchbase\n\nLinkedin\n\nAbout Texas Medical Center: Texas Medical Center (TMC) is a life sciences medical complex focused on patient care, research, education, and prevention.\n\nWebsite\n\nCrunchbase\n\nLinkedin\n\nDavid Warnock\n\nCEO & Partner of Camden Partners\n\nDavid is a Senior Partner of Camden Partners and co-founded the firm in 1995. He has over 25 years of investment experience and focuses on investments in the business and education sectors. He serves as Chairman of New Horizons Worldwide, Inc. and Calvert Education Services, LLC. In addition, he is a director of Primo Water Corporation, Questar Assessment, Inc., Ranir, LLC, Santa Rosa Consulting, Triumph Higher Education Group and Network for Good. He formerly served on the board of American Public Education, Inc., Nobel Learning Communities, Inc. Towne Park, Ltd., and National American University, all of which were Camden Partners portfolio companies. David was employed by T. Rowe Price Associates from 1983-1995. He served as President of T. Rowe Price Strategic Partners I & II as well as co-manager of the T. Rowe Price New Horizons Fund. David started his career at Welch and Forbes, Boston-based private trustees. David is also involved with numerous non-profit organizations. He is the Chairman of the Center For Urban Families and the Warnock Foundation, and was formerly the Chairman of the Greater Baltimore Committee. He is Founder and Trustee of the Green Street Academy in Baltimore City. He also serves as a trustee of the Baltimore Museum of Art and the Georgia O’Keeffe Museum. David earned a B.A. degree from the University of Delaware and a M.S. (in Finance) from the University of Wisconsin. David is also a Chartered Financial Analyst Charterholder.\n\nFollow David Warnock:\n\nCrunchbase\n\nLinkedin\n\nAbout Camden Partners, Camden Partners, Center for Urban Families, Georgia O’keeffe Museum, Pinnacle Automotive Hospitality Services, Warnock Foundation: Camden Partners provides growth capital to companies in the education, healthcare and technology-enabled business services sectors.\n\nWebsite\n\nCrunchbase\n\nLinkedin\n\nDavid Cordani\n\nPresident & CEO of Cigna\n\nDavid Cordani is the President (since 2008) and Chief Executive Officer at Cigna since December 2009. David is also a Member of the Board of Directors at Cigna since 2013. David has led Cigna’s transformation from a traditional health insurer into a leading, global health service company, with a focus on helping people improve their health, well-being and sense of security. Since becoming President and Chief Executive Officer in 2009, Cordani has successfully galvanized Cigna’s more than 35,000 employees–in more than 30 countries–around a global product and service repositioning, guided by the company’s differentiating “Go Deep, Go Global, Go Individual” strategy. Previously, David was the Chief Operating Officer from June 2008 until December 2009, President of Cigna HealthCare from 2005 until 2008 and Senior Vice President of Customer Segments and Marketing for Cigna HealthCare from 2004 until 2005. David has been employed by Cigna since 1991. David is an accomplished triathlete, having competed in more than 125 triathlons. David earned a Bachelor’s degree from Texas A&M University and an MBA from the University of Hartford.\n\nFollow David Cordani:\n\nCrunchbase\n\nLinkedin\n\nAbout Cigna: CIGNA Corporation operates as a health service company that helps people to improve the health, well-being, and peace of mind.\n\nWebsite\n\nCrunchbase\n\nLinkedin\n\nDavid E. Weekly\n\nCEO of Medcorder\n\nDavid is a nerd who likes people. David runs the product org for the datacenter software team at Google and previously helped launch internet.org at Facebook, helping to connect the species to the Internet. Before that, he started and ran Ohana (a service to help parents share videos of their kids with extended family) and PBwiki (the first private hosted wiki company), still used by millions of people a month. He was the Founding Director of Hacker Dojo, one of the world’s largest hackerspaces, located in Mountain View, and was the Founding Partner of Mexican.VC, Silicon Valley’s first seed fund for Mexican Internet startups and the best performing Mexican tech fund in history. David has been programming since he was five and graduated from Stanford with a degree in Computer Science as a President Scholar. He has worked in such widely varying technology environments as Harvard Physics Labs, MIT Lincoln Labs, Stanford Graphics Labs, atWeb (acquired by Netscape), myplay (acquired by Bertelsmann), Legato (acquired by EMC), and There.com (where he worked with Eric Ries, the inventor of The Lean Startup methodology). David has served as an advisor to dozens of technology companies, including Plaxo (acquired by Comcast), Attassa (acquired by YouSendIt), and Like.com (acquired by Google).\n\nFollow David E. Weekly:\n\nCrunchbase\n\nLinkedin\n\nAbout Medcorder: Medcorder is a mobile app that helps families to coordinate and communicate about patient care.\n\nWebsite\n\nCrunchbase\n\nLinkedin\n\nNoubar Afeyan\n\nFounder & CEO of Flagship Pioneering\n\nNoubar Afeyan is Founder, Senior Managing Partner and Chief Executive Officer at Flagship Ventures, a leading early stage venture capital firm. Noubar also leads the firm’s VentureLabs unit that invents and launches transformative startups. Noubar is a Senior Lecturer at MIT’s Sloan School of Management where he has taught courses on technology-entrepreneurship, innovation and leadership since 2000. Noubar lectures widely in the United States and internationally on diverse topics ranging from entrepreneurship, innovation and venture capital to biological engineering, drug discovery, medical technologies and renewable energy. During his 28-year career as inventor, entrepreneur, CEO and venture capitalist, Noubar has co-founded and helped build over 35 successful life science and technology startups. Noubar was Founder and Chief Executive Officer at PerSeptive Biosystems, a leader in the bio-instrumentation field that grew to over $100M in annual sales within six years from its first sales. After PerSeptive’s acquisition by Perkin Elmer/Applera Corporation in 1998, Noubar was Senior Vice President and Chief Business Officer of Applera, where he initiated and oversaw the creation of Celera Genomics. Currently Noubar serves on a number of public and private company boards including CiBO Technologies, Epiva BioSciences, Evelo BioSciences, Joule Unlimited, Kaleido BioSciences, Moderna Therapeutics, Pronutria Biosciences and Seres Therapeutics. Previously, Noubar was a Member of the founding team, Director and Investor in several highly successful ventures including Chemgenics Pharmaceuticals (acquired by Millennium Pharmaceuticals), Color Kinetics (acquired by Philips), Adnexus Therapeutics (acquired by Bristol-Myers Squibb) and Affinnova (acquired by AC Nielsen). Noubar received a Technology Pioneer 2012 award from the World Economic Forum in recognition of the breakthrough solar fuel technology being developed at Joule Unlimited. Noubar has served as Chairman of the Global Agenda Council on Chemicals, Advanced Materials and Biotechnology of the World Economic Forum as well as being a member of the Meta-Council on Emerging Technologies. Noubar is a Member of the Board of Overseers of the Boston Symphony Orchestra. In addition, he serves on the board of AmeriaBank and of UWC Dilijan International School, both of Armenia. Previously, Noubar was a Co-Founder and Member of the Board of Directors at National Competitiveness Foundation of Armenia, a private-public partnership dedicated to promoting economic development in the former Soviet Republic of Armenia. In 2008 Noubar received the Ellis Island Medal of Honor, an award granted to outstanding Americans who have distinguished themselves as United States citizens and who have enabled their ancestry groups to maintain their identities while becoming integral parts of American life. Noubar has authored numerous scientific publications and patents since earning his Ph.D. in Biochemical Engineering from MIT in 1987. Cygnal is a best-in-class team of biomedical experts and leaders collaborating to revolutionize how the world treats diseases.\n\nFollow Noubar Afeyan:\n\nCrunchbase\n\nLinkedin\n\nAbout BIND Therapeutics, Cogen Therapeutics, Cygnal Therapeutics, Ensemble Therapeutics, Flagship Pioneering, Generate Biomedicines, Harvard Business School, Indigo, Joule Unlimited Technologies, Laronde, Massachusetts Institute of Technology, Moderna Therapeutics, Omega Therapeutics, Permeon Biologics, Ring Therapeutics, Rubius Therapeutics, Seres Therapeutics: Flagship Pioneering is a venture capital firm that invests in life sciences and healthcare companies.\n\nWebsite\n\nCrunchbase\n\nLinkedin\n\nSimba Gill\n\nPresident & CEO of Evelo Biosciences\n\nSimba Gill, PhD is an entrepreneur, investor and CEO who believes passionately that science and globalization will dramatically improve life in the 21st century. Dr. Gill is currently the CEO of Evelo, Sr. Partner at Flagship Ventures, and Executive Chair of Blackfynn. Dr. Gill founded or had lead roles in moksha8, Epirus, Maxygen, Verdia, Avidia, Codexis, Systemix and Valentis, four of these companies have been taken public and three were acquired through strategic trade sales. Exit valuations were between $400M – $6B. Dr. Gill has also led, built and launched several commercial businesses/products generating annual revenues of between $150M-$2B. Dr. Gill has founded and/or had lead roles in pioneering companies in the fields of antibodies, stem cells, directed molecular evolution, immunodiagnostics and the cancer microbiome. He has also been an investor, advisor, founder and CEO of several emerging market life science companies. Dr. Gill was a Partner at TPG, focused on investments in Life Sciences and Emerging Markets. Early in his career, Dr. Gill was co-head of Worldwide Marketing for Recormon. He also led corporate and market development and strategy from inception to commercialization of the Elecsys system, which became one of the world’s most widely used immunodiagnostic platforms. Dr. Gill served on the Board of Directors of the Tuberculosis Alliance, The Djerassi Resident Artists Program and the International Advisory Board of INSEAD. Dr. Gill was also the founder of Dispatches, an in-depth written and photojournalism periodical focused on key global issues. Dr. Gill has an MBA from INSEAD and carried out his PhD with focus on developing humanized antibodies to treat cancer. This work was done at King’s College, London in collaboration with the LMB at Cambridge and Celltech.\n\nFollow Simba Gill:\n\nCrunchbase\n\nLinkedin\n\nAbout Epiva, Evelo Biosciences, moksha8 Pharmaceuticals, TPG Growth: Evelo Biosciences is dedicated to improving the lives of patients globally through the development of monoclonal microbials.\n\nWebsite\n\nCrunchbase\n\nLinkedin\n\nDaniel Grau\n\nPresident, Chief Executive Officer, and Director of Sojournix\n\nGrau co-founded and has served as Chief Executive Officer and Director at Sojournix since 2016. An experienced biotech entrepreneur and operating executive, Mr. Grau led the deal to acquire SJX-653 and has driven the rapid growth and financing of the company from startup to clinical-stage pharmaceutical business. Prior to Sojournix, Mr. Grau served as President at Heptares Therapeutics (acquired 2015), Chief Executive Officer at Cortria (acquired 2010), and Chief Operating Officer at CombinatoRx (IPO 2005). Mr. Grau currently serves as an advisor to HotSpot Therapeutics and previously served as a member of the Product Advisory Board at Concert Pharmaceuticals and as an advisor to Nimbus Therapeutics. Earlier in his career, Mr. Grau worked with multi-national pharma companies as a management consultant focused on corporate and business franchise strategy, M&A, and new product launches. Mr. Grau earned his M.Phil., M.A., and M.A.R. degrees from Yale University, where he was awarded a Mellon Fellowship, the Day Graduate Prize, and a Bass Fellowship, and a B.A. with High Honors from Davidson College, where he held a Dana Honor Scholarship, a Montgomery Scholarship, and was elected to Phi Beta Kappa.\n\nFollow Daniel Grau:\n\nCrunchbase\n\nLinkedin\n\nAbout Cortria Corporation, Heptares Therapeutics, Sojournix: Sojournix is a biotechnology company developing innovative medicines for women’s health and endocrine disorders.\n\nWebsite\n\nCrunchbase\n\nLinkedin\n\nAlexandre Winter\n\nCEO, co-founder of Norbert Health\n\nAlex is both a computer vision geek and a repeat tech entrepreneur. Born and raised in France, a proud Brooklynite today, Alex is currently CEO and co-founder of a stealth mode health tech startup. Alex is also helping several VC funds as a venture partner – Scrum Ventures, Serena. Prior to this project, Alex was leading the Artificial Intelligence team at Arlo. Alex was the CEO and founder of Placemeter, a New-York based startup that quantifies human activity in cities using computer vision and video feeds. Placemeter raised 8m of venture capital and was sold to Netgear in December 2016. Prior to placemeter, Alex co-founded LTU Technologies, a venture backed startup, pioneer in large scale image search by content. As a CTO then CEO of the company, Alex helped bring LTU to profitability in three years. LTU was successfully acquired by a Japanese company listed on the Tokyo Stock Exchange. Prior to LTU, Alex was a researcher in Computer Vision at INRIA. He also worked at Airbus, building vision based missile guidance systems. Alex holds an MSc and a PhD in Image Recognition from Telecom ParisTech, holds 9 patents in the field. Alex also advises various startups in New York, and is a mentor of the Techstars NYC program. Prior to LTU, Alexandre was a researcher at INRIA in Paris, and a missile guidance engineer at Aerospatiale, now EADS. Alexandre holds a PhD in Computer Vision from Telecom Paristech and 10 patents in the field.\n\nFollow Alexandre Winter:\n\nCrunchbase\n\nLinkedin\n\nAbout Norbert Health, Serena, Stealth mode health tech startup: Norbert Health develops a home medical pod that monitors the health of families using contactless sensors.\n\nWebsite\n\nCrunchbase\n\nLinkedin\n\nMark Bertolini\n\nChairman and Chief Executive Officer of Aetna\n\nMark Bertolini is Chairman, Chief Executive Officer and President of Aetna, a Fortune 100 diversified health care benefits company with more than $47.2 billion in 2013 revenue. Aetna serves an estimated 44 million people with information and resources to help them make better informed decisions about their health care and has operations in North America, Asia, Europe and the Middle East. Bertolini assumed the role of CEO on November 29, 2010 and of Chairman on April 8, 2011. Bertolini joined Aetna in 2003 as head of Aetna’s Specialty Products. In July 2007, he was named president, responsible for all of Aetna’s businesses and operations across the company’s broad range of health care products and related services – including medical, pharmacy, dental, behavioral health, group life and disability plans, as well as medical management capabilities and health care management services for Medicaid plans. Prior to serving as Aetna’s president, Bertolini was executive vice president and head of Aetna’s regional businesses, which included the company’s individual, retiree, small group and middle market segments, as well as numerous product, network and service areas. Recognized as an accessible, forward-thinking and solutions-oriented leader, Bertolini is actively engaged in the national dialogue on health care reform, meeting regularly with state and federal policymakers to advocate for measures that increase access, lower costs and improve quality of health care. He is a strong advocate of market-based solutions, the expansion and use of health information technology, and the sustainability of the employer-based system. Firmly committed to diversity and inclusion, Bertolini also serves as the company’s executive sponsor for diversity, participates in several Aetna employee resource groups, and maintains a blog to communicate with employees. Among his civic activities, Bertolini serves on the Board of Directors of the U.S.-China Business Council, the Hole in the Wall Gang Camp, an organization founded by Paul Newman that serves children with cancer and other serious illnesses, and FIDELCO, an organization that breeds and trains guide dogs for the visually disabled. In 2009, he was elected the first straight ally board member of the National Gay and Lesbian Chamber of Commerce. Bertolini has been honored for his leadership by numerous universities and organizations, including the National Italian American Foundation, Outward Bound, the National Kidney Registry, Out & Equal Workplace Advocates, the Quinnipiac University Business School, and Wayne State University School of Business. Prior to joining Aetna, Bertolini held executive positions at Cigna, NYLCare Health Plans, and SelectCare, Inc., where he served as president and chief executive officer. Born and raised in Detroit, Bertolini held various jobs throughout high school and college, including assembly work at a Ford Motor Company plant and various caregiver roles in health care delivery.Bertolini is a spinal cord injury survivor and is partially disabled as the result of a severe skiing accident in 2004. In 2007, Bertolini donated a kidney to his son. His previous work and personal experiences with the health care system are foundational to his dedication to improving the patient experience and addressing the longstanding challenges facing the U.S. health care system. Bertolini holds an undergraduate degree in business administration/finance from Wayne State University and a MBA in finance from Cornell University.\n\nFollow Mark Bertolini:\n\nCrunchbase\n\nLinkedin\n\nAbout Aetna: Aetna a diversified health care benefits company, provides individuals and many others with innovative benefits, products, and services.\n\nWebsite\n\nCrunchbase\n\nLinkedin\n\nCary Gunn\n\nCEO & Founder of Genalyte\n\nDr. Cary Gunn — who drives Genalyte’s strategic vision, direction, culture and success — has been blazing trails in the technology community for almost 30 years. Prior to leading Genalyte, Cary served as co-founder and chief technical officer of Luxtera, a developer of innovative optical solutions; his military career includes almost 10 years in the United States Air Force, where he was responsible for launching GPS satellites. Holding 81 (and counting) issued U.S. patents, Cary has been recognized in publications including the MIT Technology Review, which named him a Top Young Innovator in 2003. Five years later, Cary’s achievements in silicon photonics were awarded with the Optical Society of America Adolph Lomb Medal and the Berthold-Leibinger Foundation Innovation Prize. He received his bachelor’s degree in applied physics and organic chemistry from the United States Air Force Academy and his PhD in electrical engineering from the California Institute of Technology (Caltech). At Genalyte, Cary is proud to pioneer technology that has “a positive impact on life and human health.”\n\nFollow Cary Gunn:\n\nCrunchbase\n\nLinkedin\n\nAbout Genalyte: Genalyte is a life sciences company developing and commercializing innovative next-generation multiplexing technology.\n\nWebsite\n\nCrunchbase\n\nLinkedin"
    }
}